S

St. Francis Cancer Center | Greenville, SC

Research site

(Unclaimed)

Location

104 Innovation Drive, Greenville, South Carolina, United States of America

Site insights

Top conditions

Top treatments

AB122

GC4419

Azacitidine

MGCD516

BB-1701

Lintuzumab

APL-101

azacitidine

Venetoclax

Magrolimab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 9 total trials

A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

This trial will look at a drug called SEA-CD70 with and without azacitidine, to find out if it is safe for participants with myelodysplastic syndrome...

Enrolling

Myelodysplastic Syndrome

Acute Myeloid Leukemia

Drug: SEA-CD70

Drug: azacitidine

Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)

The optimal treatment for Stage I or Stage IIA non-small cell lung cancer (NSCLC) remains controversial. Radiographic surveillance alone has been rec...

Active, not recruiting

Non-Small Cell Lung Cancer

Other: 14-Gene Prognostic Assay

Drug: Adjuvant Chemotherapy

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA)

To assess:* efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification...

Enrolling

Glioblastoma Multiforme

Brain Tumor

Drug: APL-101 Oral Capsules